GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Earth Science Tech ETST · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.10

+11.36%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$35.7m

FY2017FY2026

Net income

$3.6m

FY2017FY2026

Free cash flow

$1.2m

FY2017FY2026

Shareholders' equity

$7.0m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$35.7m$33.1m$12.0m$48,537$14,123$140,902$526,139$770,635$463,108$428,199
Research and development—————$9,000$76,113$338,856$150,451—
Operating income$4.3m$3.4m$1.3m−$936,683−$226,706−$4.3m−$823,790−$2.1m−$1.7m−$1.1m
Net income$3.6m$3.3m$812,139−$365,405$3.2m−$4.4m−$1.5m−$2.2m−$1.7m−$1.1m
Diluted earnings per share0.010.010.00-0.000.03-0.08-0.03-0.04-0.03-0.02

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$9.0m$7.1m$3.9m$2.7m$76,942$64,564$154,552$411,071$345,326$427,490
Cash and short-term investments$2.2m$2.1m$697,721$35,756$26,942$16,161$30,723$127,524$72,038$172,295
Total liabilities$1.9m$3.2m$1.6m$1.6m$1.9m$5.1m$980,051$617,730$429,307$418,141
Debt$96,206$401,236$246,588$974,106$780,694$650,440$498,670$202,858$59,558$59,558
Shareholders' equity$7.0m$3.9m$2.2m$1.1m−$1.8m−$5.0m−$825,499−$206,659−$83,981$9,349
Shares outstanding290m293m303m315m102m53m46m54m51m61m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$1.9m$4.4m$1.2m−$1.0m−$168,106−$196,686−$518,620−$1.6m−$1.7m−$1.1m
Capital spending−$756,619−$753,165−$26,520—−$1,712————−$146
Free cash flow$1.2m$3.6m$1.2m−$1.0m−$169,818−$196,686−$518,620−$1.6m−$1.7m−$1.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$9.0m$9.5m$8.4m$9.1m$8.8m$8.7m$7.4m$8.5m
Operating income$840,707$1.4m$1.6m$802,282$496,972$1.6m$436,775$829,560
Net income$724,192$1.3m$910,367$966,822$465,039$1.2m$206,411$798,368
Diluted earnings per share0.000.000.000.000.000.000.000.00
Cash from operations—————$1.0m——
Total assets$10.4m$9.0m$8.1m$8.7m$7.8m$7.1m$5.7m$5.0m
Cash and short-term investments$2.8m$2.2m$1.5m$2.2m$1.8m$2.1m$1.6m$1.5m
Debt$213,969$96,206$160,697$205,913$215,022$363,358$916,331$197,341
Shareholders' equity$7.3m$7.0m$5.7m$5.0m$4.2m$3.9m$3.3m$3.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue802.6%202.5%54.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin11.3%10.1%4.5%-3.4%
Net margin10.0%9.1%7.6%-2.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings8.011.846.6-60.10.3-0.0-0.1-0.0-0.3-1.1
Price to sales0.81.23.2452.167.20.80.30.11.22.8

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return23%160%303%445%34%-19%-83%-5%148%1468%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.